Medication info
Widiang Duo Tablet 5/500 mg

Widiang Duo Tablet 5/500 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Widus Pharmaceutical Co., Ltd.
Appearance
Orange-yellow, biconvex, oval film-coated tablet
Packaging
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202201372 · Approved 2022.04.04 · Insurance code 660703950

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were previously taking. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient medicines. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Widus Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty in blood sugar control
  • Type 2 diabetes
  • cardiovascular disease
  • risk of cardiovascular event occurrence
View approved original text

This drug is used to help control blood sugar levels in patients with Type 2 diabetes. It is particularly suitable for adult patients whose dietary and exercise therapy is insufficient, and it can effectively lower blood sugar when taken together with empagliflozin and metformin. It can also be used in adult diabetic patients with cardiovascular disease; however, it is important to follow expert guidance regarding related cardiovascular events. Therefore, this drug is used to improve blood sugar control and assist in diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were previously taking. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient medicines. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This drug is an anti-diabetic agent that helps in controlling blood sugar. However, it can cause a rare complication called severe lactic acidosis, so caution is needed. There is a risk of hypoglycemia when used with other anti-diabetic medications, so care should be taken. Patients with poor kidney function or acute kidney injury should not take this drug. It should also be avoided in the presence of serious illnesses such as acute infections, heart failure, and acute myocardial infarction. Before and after examinations using iodine-based radiocontrast agents, this drug should be discontinued and restarted only after kidney function has returned to normal. Pregnant or breastfeeding women should avoid taking this drug for safety. Regular kidney function tests should be conducted because this drug can affect kidney function; special caution is necessary for the elderly or those showing signs of dehydration. There is a risk of hypoglycemia, so dosage adjustments may be necessary when used with insulin or sulfonylurea medications. Increased urination or the occurrence of urinary tract infections and genital infections may happen during treatment; any unusual symptoms should be reported to a healthcare provider. Prolonged use may cause Vitamin B12 deficiency, so it is advisable to check blood levels of Vitamin B12 periodically. Excessive alcohol intake should be avoided, as it may increase the risk of lactic acidosis. This drug should be discontinued for more than 48 hours before surgery and restarted after kidney function has recovered post-surgery. This drug is not recommended for children, and dosage adjustments should be made for the elderly based on their kidney function. In cases of overdose, there is a risk of lactic acidosis, and immediate medical attention should be sought. Store this drug out of reach of children and keep it in its original container.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 177 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • urticaria
  • erythema multiforme
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vulvovaginitis
  • balanitis
  • perineal necrosis
  • vascular stent stenosis
  • vascular stent thrombosis
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • headache
  • dizziness
  • positional dizziness
  • drowsiness
  • insomnia
  • anxiety
  • depression
  • palpitations
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • ear pain
  • positional vertigo
  • dizziness
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual phlegm
  • weight loss
  • weight gain
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • ligament injury
  • ligament sprain
  • musculoskeletal pain
  • lumbar pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataracts
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • macular fibrosis
  • ocular discomfort
  • conjunctival congestion
  • pathological myopia
  • retinal detachment
  • retinal deposits
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasopharyngitis
  • herpes zoster
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • appendiceal abscess
  • appendicitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • meningitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • epigastric pain
  • dental caries
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • hematochezia
  • hemorrhoids
  • colonic bleeding
  • pancreatic cyst
  • rectal pain
  • toothache
  • fever
  • asthenia
  • chest discomfort
  • chest pain
  • facial swelling
  • edema
  • strange sensation
  • pain
  • pain at the puncture site
  • limb injury
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • unstable angina
  • hypertension
  • cervical inflammation
  • vulvar pruritus
  • genital pruritus
  • hypoglycemia
  • decreased appetite
  • thirst
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • dyslipidemia
  • glaucoma
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Orange-yellow, biconvex, oval film-coated tablet

Package unit

10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.